Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

McMaster University

$89,919.00

Developing RNA-cleaving DNAzymes as Molecular Tools for Cancer Study and as Cancer Therapeutics

EF 2008-09

Résumé
DNA is widely known as the material used by all living organisms on Earth to store and transmit genetic information. Recently however, DNA has been shown to have other talents as well, one of which is to act as a catalyst to make or break molecules of biological significance. DNA-made catalysts, known as 'DNAzymes', are usually made by scientists either to address fundamental scientific questions or to provide unique solutions to problems of medical importance. Because DNA is an exceptionally stable polymer and can be easily produced commercially, DNAzymes with tailor-made functions are regarded as very desirable molecular tools and are being tested in many research labs around the world as diagnostic kits and therapeutic agents. In this project, we will study two kinds of DNAzymes. RNase DNAzymes: they can be viewed as special molecular scissors, designed to cut an extremely important class of biological molecules known as 'RNA'. RNase DNAzymes are medically valuable because they can catalytically destroy any RNA of interest (such as a cancer-causing RNA molecule). Signaling DNAzymes: they function like a beacon at molecular level, generating a signal under a specific condition. Signaling DNAzymes can be used to create novel diagnostic tools for detection of diseases such as cancer. The proposed work is to design DNAzyme based molecular tools for facilitating biomedical research on cancer and develop some potent DNAzymes into therapeutic or diagnostic agents for this disease.
Programme
Operating Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
183786
Name
Li Yingfu
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Cancer Biology & Therapeutics
Projecttitle
Developing RNA-cleaving DNAzymes as Molecular Tools for Cancer Study and as Cancer Therapeutics
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$89,919
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Biosensor; Cancer; Dnazyme; In Vitro Selection; Rna; Therapeutics
Abstract
DNA is widely known as the material used by all living organisms on Earth to store and transmit genetic information. Recently however, DNA has been shown to have other talents as well, one of which is to act as a catalyst to make or break molecules of biological significance. DNA-made catalysts, known as 'DNAzymes', are usually made by scientists either to address fundamental scientific questions or to provide unique solutions to problems of medical importance. Because DNA is an exceptionally stable polymer and can be easily produced commercially, DNAzymes with tailor-made functions are regarded as very desirable molecular tools and are being tested in many research labs around the world as diagnostic kits and therapeutic agents. In this project, we will study two kinds of DNAzymes. RNase DNAzymes: they can be viewed as special molecular scissors, designed to cut an extremely important class of biological molecules known as 'RNA'. RNase DNAzymes are medically valuable because they can catalytically destroy any RNA of interest (such as a cancer-causing RNA molecule). Signaling DNAzymes: they function like a beacon at molecular level, generating a signal under a specific condition. Signaling DNAzymes can be used to create novel diagnostic tools for detection of diseases such as cancer. The proposed work is to design DNAzyme based molecular tools for facilitating biomedical research on cancer and develop some potent DNAzymes into therapeutic or diagnostic agents for this disease.
Competitiondate
200810
Approvedterm2
1 yr 0 mth
Pinamesdelim
Li, Yingfu
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $89,919~ $0~